iCAD to highlight AI for tomosynthesis at ECR

By AuntMinnieEurope.com staff writers

February 26, 2019 -- iCAD plans to highlight its artificial intelligence (AI) software for digital breast tomosynthesis (DBT), ProFound AI, at the upcoming ECR 2019 in Vienna.

The software was cleared on 7 December 2018 by the U.S. Food and Drug Administration (FDA). It detects malignant soft-tissue densities and calcifications while offering radiologists scoring information that indicates the likelihood that a detection or case is malignant, the company said.

At the meeting, iCAD will also preview ProFound AI for 2D mammography, currently pending the CE Mark.

Copyright © 2019 AuntMinnieEurope.com

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking